First Wilshire Securities Management’s Trinity Biotech TRIB Stock Holding History

First Wilshire Securities Management’s Portfolio TRIB Stock Details TRIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-105,929	Closed	-$547K	–	96
2019 Q4	$547K	Sell	105,929 -48,697	-31%	-$232K	0.21%	63
2019 Q3	$935K	Sell	154,626 -4,216	-3%	-$36.6K	0.35%	50
2019 Q2	$1.31M	Sell	158,842 -37,403	-19%	-$445K	0.52%	49
2019 Q1	$2.8M	Sell	196,245 -1,684	-0.9%	-$23.1K	0.95%	38
2018 Q4	$2.27M	Sell	197,929 -5,963	-3%	-$92.1K	0.85%	38
2018 Q3	$4.08M	Sell	203,892 -2,269	-1%	-$49.3K	1.2%	31
2018 Q2	$5.15M	Buy	206,161 +5,986	+3%	+$144K	1.54%	25
2018 Q1	$5.16M	Sell	200,175 -5,150	-3%	-$140K	1.43%	27
2017 Q4	$5.24M	Sell	205,325 -8,245	-4%	-$213K	1.43%	28
2017 Q3	$5.99M	Sell	213,570 -2,314	-1%	-$64.5K	1.7%	22
2017 Q2	$6.48M	Buy	215,884 +840	+0.4%	+$23.8K	1.85%	18
2017 Q1	$6.41M	Buy	215,044 +38,330	+22%	+$1.2M	1.85%	18
2016 Q4	$6.11M	Buy	+176,714	New	+$6.09M	1.75%	20

Other funds holding TRIB

SCM

Stonehill Capital Management New York $197M AUM 96.45% 1-Year Est. Return

HAIM

Hunter Associates Investment Management Pittsburgh, Pennsylvania $756M AUM 19.99% 1-Year Est. Return

PIM

Paradice Investment Management Denver, Colorado $532M AUM 29.6% 1-Year Est. Return

Heartland Advisors Milwaukee, Wisconsin $1.96B AUM 28.26% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

ICM

Invenomic Capital Management Boston, Massachusetts $2.18B AUM 0.03% 1-Year Est. Return

Fondren Management Houston, Texas $16.9M AUM 5.82% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

First Wilshire Securities Management's TRIB Position: Q1 2020 in Review

First Wilshire Securities Management sold out of Trinity Biotech (TRIB) in Q1 2020, closing a stake of 105,929 shares — an estimated $547K sold.

First Wilshire Securities Management first reported a position in TRIB in Q4 2016 and held it in 13 quarters. The position peaked at $6.48M in Q2 2017. 23 funds tracked by Wall St. Rank hold TRIB as of Q1 2020.

First Wilshire Securities Management reported no remaining Trinity Biotech position as of Q1 2020 after selling out during the quarter.
First Wilshire Securities Management sold 105,929 Trinity Biotech shares in Q1 2020, an estimated $547K.
First Wilshire Securities Management first reported a position in Trinity Biotech in Q4 2016 and held it in 13 quarters.
First Wilshire Securities Management's Trinity Biotech position peaked at $6.48M in Q2 2017.
23 funds tracked by Wall St. Rank held Trinity Biotech as of Q1 2020.

Based on First Wilshire Securities Management's 13F filing for Q1 2020, filed 15 May 2020.